Pancreatitis Trial, Recruiting (NCT06822413)

Pancreatitis Trial, Recruiting NCT06822413 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Pancreatitis

Printed from Voxsanity (voxsanity.com.au) — NCT06822413 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a malignant (cancerous) tumor through a tissue test, specifically colorectal cancer, stomach cancer, liver cancer, pancreatic cancer, or esophageal cancer.
You are in normal physical health and do not have any cancer or pre-cancerous conditions.
You have been diagnosed with a malignant tumor but have not yet received any treatment such as chemotherapy, surgery, radiation therapy, immunotherapy, or any other cancer treatment.
You have been diagnosed with a pre-cancerous condition or a non-cancerous disease confirmed by a tissue test.

Who may not be able to join:

Your cancer has spread (metastasized) to other parts of the body, or you have been diagnosed with two or more different types of cancer at the same time.
You have already completed or received treatment for cancer.

Important: Always verify eligibility with the trial site directly before applying.

Please note: This information is provided to help you understand the trial criteria only. It is not medical advice, and it does not mean this trial is or is not right for you. Please speak with your doctor and contact the trial site directly to find out if you may be eligible.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kefeng Ding, MD, Department of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine

Phone: +86 18720996980

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06822413

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatitis

Trial contact: +86 18720996980

More information: https://clinicaltrials.gov/study/NCT06822413

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a malignant (cancerous) tumor through a tissue test, specifically colorectal cancer, stomach cancer, liver cancer, pancreatic cancer, or esophageal cancer.
You are in normal physical health and do not have any cancer or pre-cancerous conditions.
You have been diagnosed with a malignant tumor but have not yet received any treatment such as chemotherapy, surgery, radiation therapy, immunotherapy, or any other cancer treatment.
You have been diagnosed with a pre-cancerous condition or a non-cancerous disease confirmed by a tissue test.

Who may not be able to join:

Your cancer has spread (metastasized) to other parts of the body, or you have been diagnosed with two or more different types of cancer at the same time.
You have already completed or received treatment for cancer.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Registry

ClinicalTrials.gov

Start date

1 September 2022

Est. completion

15 May 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

A Deep Learning Model for High-Accuracy Pan-Cancer Classification

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov